Gazyva 1,000 MG/40 ML vial 40ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXR6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,326
Award facts
- Contract value 100% obligated
- $10,325.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,325.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 mg/40 ml vials of GAZYVA (obinutuzumab), a monoclonal antibody used in oncology treatments. The contract was awarded on January 27, 2026, with an ultimate completion date of February 18, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veteran healthcare programs. The company holds a significant $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical through December 2026, which serves as the vehicle for this and similar pharmaceutical deliveries. This prime contract enables AmerisourceBergen to supply a comprehensive range of medications, vaccines, and medical supplies globally to support Department of Defense and other federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FXR6X?
SPE2DR26FXR6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FXR6X worth?
The government has obligated $10,326 on SPE2DR26FXR6X.
Is contract SPE2DR26FXR6X an order under another contract?
Yes. SPE2DR26FXR6X is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR6X competed?
The extent of competition for SPE2DR26FXR6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award